Testosterone lotion - Acrux

Drug Profile

Testosterone lotion - Acrux

Alternative Names: Axeron; Axiron; LY-900011; Testosterone Metered-Dose Lotion

Latest Information Update: 25 Mar 2017

Price : $50

At a glance

  • Originator Acrux
  • Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Eye disorder therapies; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Androgen receptor agonists; Testosterone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Hypogonadism

Most Recent Events

  • 01 Apr 2015 Eli Lilly completes a phase III trial for Hypogonadism in USA, Argentina, Brazil, Germany, Italy, South Korea, Spain and the United Kingdom (NCT01816295; EudraCT 2012-004866-16)
  • 23 Jan 2015 Biomarkers information updated
  • 08 Jan 2015 Registered for Hypogonadism in Austria, Denmark, Finland, Norway and Sweden (Transdermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top